TREAT ctDNA Elacestrant
Conditions: ER-positive Breast Cancer; HER2-negative Breast Cancer; Stage IIB Breast Cancer; Stage III Breast Cancer Interventions: Drug: Elacestrant; Drug: Tamoxifen; Drug: Letrozole 2.5mg; Drug: Anastrozole 1mg; Drug: Exemestane 25 MG Sponsors: European Organisation for Research and Treatment of Cancer - EORTC; Breast International Group; Menarini Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials